Z. Jesse Shao, Ph.D., R.Ph.

Vice President, CMC

Z. Jesse Shao, Ph.D., R.Ph., is the vice president of CMC at BlossomHill Therapeutics. He has more than 25 years of experience in pharmaceutical research and development, notably in controlled-release drug delivery. Dr. Shao has held various technical and leadership positions of increasing responsibilities at Schering-Plough, Pfizer, Arena Pharmaceuticals and FibroGen. Prior to joining BlossomHill, he was executive director at FibroGen, where he contributed to the approval and launch of roxadustat (EVRENZO®) in the EU, Japan and China. At Arena Pharmaceuticals, he led the successful drug product technology transfer, approval and launch of lorcaserin (BELVIQ® and BELVIQ XR®).

Dr. Shao received his doctorate in industrial and physical pharmacy from Purdue University in West Lafayette, Ind. Dr. Shao received his Bachelor of Science in pharmacy from Peking University and hisMaster of Science in physical pharmacy from the University of Cincinnati. Additionally, Dr. Shao is a registered pharmacist in New Jersey, an inventor of numerous patents and an author of over 30 publications.